YI
111, Inc.
Medical - Pharmaceuticals
Market Cap$52M
5Y Perf.-91.8%
Compare Stocks
5 / 10Try these comparisons:
Stock Comparison
YI vs PINC vs TDOC vs MCK vs CAH
Revenue, margins, valuation, and 5-year total return — side by side.
PINC
Premier, Inc.
Medical - Healthcare Information Services
Market Cap$2.34B
5Y Perf.-19.2%
TDOC
Teladoc Health, Inc.
Medical - Healthcare Information Services
Market Cap$1.31B
5Y Perf.-95.8%
MCK
McKesson Corporation
Medical - Distribution
Market Cap$90.21B
5Y Perf.+364.2%
CAH
Cardinal Health, Inc.
Medical - Distribution
Market Cap$43.22B
5Y Perf.+235.8%
YI vs PINC vs TDOC vs MCK vs CAH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | YI | PINC | TDOC | MCK | CAH |
|---|---|---|---|---|---|
| Industry | Medical - Pharmaceuticals | Medical - Healthcare Information Services | Medical - Healthcare Information Services | Medical - Distribution | Medical - Distribution |
| Market Cap | $52M | $2.34B | $1.31B | $90.21B | $43.22B |
| Revenue (TTM) | $14.18B | $1.00B | $2.51B | $403.43B | $250.55B |
| Net Income (TTM) | $-74M | $-24M | $-171M | $4.76B | $1.56B |
| Gross Margin | 5.0% | 72.6% | 65.6% | 3.6% | 3.7% |
| Operating Margin | -0.0% | -0.0% | -7.6% | 1.5% | 0.9% |
| Forward P/E | — | 20.8x | — | 16.7x | 17.1x |
| Total Debt | $257M | $282M | $1.04B | $8.61B | $9.35B |
| Cash & Equiv. | $462M | $84M | $781M | $3.98B | $3.87B |
YI vs PINC vs TDOC vs MCK vs CAH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
YI
PINC
TDOC
MCK
CAH
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| 111, Inc. (YI) | 100 | 8.2 | -91.8% |
| Premier, Inc. (PINC) | 100 | 80.8 | -19.2% |
| Teladoc Health, Inc. (TDOC) | 100 | 4.2 | -95.8% |
| McKesson Corporation (MCK) | 100 | 464.2 | +364.2% |
| Cardinal Health, In… (CAH) | 100 | 335.8 | +235.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: YI vs PINC vs TDOC vs MCK vs CAH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: MCK leads in 4 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Cardinal Health, Inc. is the stronger pick specifically for capital preservation and lower volatility and recent price momentum and sentiment. PINC also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
YI
111, Inc.
The Lower-Volatility Pick
YI lags the leaders in this set but could rank higher in a more targeted comparison.
Best for: healthcare exposure
PINC
Premier, Inc.
The Defensive Pick
PINC ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.21, Low D/E 18.4%, current ratio 0.64x
- 3.0% yield, 1-year raise streak, vs CAH's 1.1%, (2 stocks pay no dividend)
Best for: sleep-well-at-night
TDOC
Teladoc Health, Inc.
The Healthcare Pick
Among these 5 stocks, TDOC doesn't own a clear edge in any measured category.
Best for: healthcare exposure
MCK
McKesson Corporation
The Growth Play
MCK carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 12.4%, EPS growth 49.2%, 3Y rev CAGR 13.4%
- 339.0% 10Y total return vs CAH's 158.8%
- 12.4% revenue growth vs PINC's -10.9%
- Lower P/E (16.7x vs 17.1x)
Best for: growth exposure and long-term compounding
CAH
Cardinal Health, Inc.
The Income Pick
CAH is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 20 yrs, beta 0.01, yield 1.1%
- Beta 0.01, yield 1.1%, current ratio 0.94x
- Beta 0.01 vs TDOC's 1.89
- +26.1% vs YI's -21.3%
Best for: income & stability and defensive
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | MCK | 12.4% revenue growth vs PINC's -10.9% |
| Value | MCK | Lower P/E (16.7x vs 17.1x) |
| Quality / Margins | MCK | 1.2% margin vs TDOC's -6.8% |
| Stability / Safety | CAH | Beta 0.01 vs TDOC's 1.89 |
| Dividends | PINC | 3.0% yield, 1-year raise streak, vs CAH's 1.1%, (2 stocks pay no dividend) |
| Momentum (1Y) | CAH | +26.1% vs YI's -21.3% |
| Efficiency (ROA) | MCK | 5.7% ROA vs TDOC's -5.9%, ROIC 74.5% vs -11.5% |
YI vs PINC vs TDOC vs MCK vs CAH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
FY 2025
FY 2025
FY 2026
FY 2025
YI vs PINC vs TDOC vs MCK vs CAH — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLMCKLAGGINGTDOC
Who Leads Where
MCK leads in 2 of 6 categories
YI leads 1 • CAH leads 1 • PINC leads 0 • TDOC leads 0 • 2 tied
Explore the data ↓TDOCTeladoc Health, Inc.
0leads
PINCPremier, Inc.
0leads
CAHCardinal Health, Inc.
1leads
YI111, Inc.
1leads
MCKMcKesson Corporation
2leads
6 Total Categories
CATEGORYLEADERvs YIvs CAHMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
MCK3/6
Valuation MetricsMultiples, price ratios, and targets
YI3/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
MCK5/9
Total Returns1Y, 3Y, 5Y total returns with dividends
CAH3/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
MCK leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MCK is the larger business by revenue, generating $403.4B annually — 402.2x PINC's $1.0B. MCK is the more profitable business, keeping 1.2% of every revenue dollar as net income compared to TDOC's -6.8%. On growth, CAH holds the edge at +11.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | YI111, Inc. | PINCPremier, Inc. | TDOCTeladoc Health, I… | MCKMcKesson Corporat… | CAHCardinal Health, … |
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $14.2B | $1.0B | $2.5B | $403.4B | $250.5B |
| EBITDAEarnings before interest/tax | $11M | $118M | $42M | $6.8B | $3.2B |
| Net IncomeAfter-tax profit | -$74M | -$24M | -$171M | $4.8B | $1.6B |
| Free Cash FlowCash after capex | $97M | $265M | $251M | $6.0B | $4.4B |
| Gross MarginGross profit ÷ Revenue | +5.0% | +72.6% | +65.6% | +3.6% | +3.7% |
| Operating MarginEBIT ÷ Revenue | -0.0% | -0.0% | -7.6% | +1.5% | +0.9% |
| Net MarginNet income ÷ Revenue | -0.5% | -2.4% | -6.8% | +1.2% | +0.6% |
| FCF MarginFCF ÷ Revenue | +0.7% | +26.4% | +10.0% | +1.5% | +1.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -6.4% | -3.3% | -2.5% | +6.0% | +11.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -36.6% | -70.0% | +32.1% | +37.0% | -19.5% |
MCK leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
YI leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 19.2x trailing earnings, MCK trades at a 85% valuation discount to PINC's 128.5x P/E. On an enterprise value basis, YI's 7.8x EV/EBITDA is more attractive than PINC's 21.3x.
| Metric | YI111, Inc. | PINCPremier, Inc. | TDOCTeladoc Health, I… | MCKMcKesson Corporat… | CAHCardinal Health, … |
|---|---|---|---|---|---|
| Market CapShares × price | $52M | $2.3B | $1.3B | $90.2B | $43.2B |
| Enterprise ValueMkt cap + debt − cash | $22M | $2.5B | $1.6B | $94.9B | $48.7B |
| Trailing P/EPrice ÷ TTM EPS | -5.47x | 128.45x | -6.36x | 19.19x | 28.47x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.79x | — | 16.66x | 17.09x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.43x | — |
| EV / EBITDAEnterprise value multiple | 7.82x | 21.35x | 15.65x | 15.27x | 15.88x |
| Price / SalesMarket cap ÷ Revenue | 0.02x | 2.31x | 0.52x | 0.22x | 0.19x |
| Price / BookPrice ÷ Book value/share | 0.93x | 1.70x | 0.92x | 11.63x | — |
| Price / FCFMarket cap ÷ FCF | 1.43x | 7.33x | 4.58x | 14.66x | 23.36x |
YI leads this category, winning 3 of 6 comparable metrics.
Profitability & Efficiency
MCK leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MCK delivers a 3.0% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-21 for YI. PINC carries lower financial leverage with a 0.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to MCK's 1.10x. On the Piotroski fundamental quality scale (0–9), YI scores 7/9 vs PINC's 4/9, reflecting strong financial health.
| Metric | YI111, Inc. | PINCPremier, Inc. | TDOCTeladoc Health, I… | MCKMcKesson Corporat… | CAHCardinal Health, … |
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -21.4% | -1.6% | -12.4% | +3.0% | — |
| ROA (TTM)Return on assets | -2.7% | -0.8% | -5.9% | +5.7% | +2.8% |
| ROICReturn on invested capital | +1.1% | +0.0% | -11.5% | +74.5% | +33.8% |
| ROCEReturn on capital employed | +0.5% | +0.0% | -10.0% | +43.1% | +19.2% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 | 6 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.67x | 0.18x | 0.75x | 1.10x | — |
| Net DebtTotal debt minus cash | -$206M | $198M | $259M | $4.6B | $5.5B |
| Cash & Equiv.Liquid assets | $462M | $84M | $781M | $4.0B | $3.9B |
| Total DebtShort + long-term debt | $257M | $282M | $1.0B | $8.6B | $9.3B |
| Interest CoverageEBIT ÷ Interest expense | -0.05x | 1.13x | -8.76x | 33.79x | 6.38x |
MCK leads this category, winning 5 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
CAH leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MCK five years ago would be worth $37,043 today (with dividends reinvested), compared to $514 for TDOC. Over the past 12 months, CAH leads with a +26.1% total return vs YI's -21.3%. The 3-year compound annual growth rate (CAGR) favors CAH at 31.1% vs YI's -39.8% — a key indicator of consistent wealth creation.
| Metric | YI111, Inc. | PINCPremier, Inc. | TDOCTeladoc Health, I… | MCKMcKesson Corporat… | CAHCardinal Health, … |
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +119.2% | — | +2.8% | -10.5% | -10.2% |
| 1-Year ReturnPast 12 months | -21.3% | +23.1% | +2.4% | +7.2% | +26.1% |
| 3-Year ReturnCumulative with dividends | -78.2% | +14.8% | -72.2% | +102.1% | +125.5% |
| 5-Year ReturnCumulative with dividends | -94.6% | -8.6% | -94.9% | +270.4% | +232.0% |
| 10-Year ReturnCumulative with dividends | -95.6% | -4.6% | -38.7% | +339.0% | +158.8% |
| CAGR (3Y)Annualised 3-year return | -39.8% | +4.7% | -34.7% | +26.4% | +31.1% |
CAH leads this category, winning 3 of 6 comparable metrics.
Risk & Volatility
Evenly matched — PINC and MCK each lead in 1 of 2 comparable metrics.
Risk & Volatility
MCK is the less volatile stock with a -0.02 beta — it tends to amplify market swings less than TDOC's 1.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PINC currently trades 98.2% from its 52-week high vs YI's 54.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | YI111, Inc. | PINCPremier, Inc. | TDOCTeladoc Health, I… | MCKMcKesson Corporat… | CAHCardinal Health, … |
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.27x | 0.21x | 1.89x | -0.02x | 0.01x |
| 52-Week HighHighest price in past year | $11.17 | $28.79 | $9.77 | $999.00 | $233.60 |
| 52-Week LowLowest price in past year | $2.48 | $20.62 | $4.40 | $637.00 | $137.75 |
| % of 52W HighCurrent price vs 52-week peak | +54.2% | +98.2% | +74.2% | +73.7% | +78.6% |
| RSI (14)Momentum oscillator 0–100 | 30.8 | 65.0 | 76.1 | 21.0 | 28.6 |
| Avg Volume (50D)Average daily shares traded | 13K | 0 | 5.2M | 782K | 1.8M |
Evenly matched — PINC and MCK each lead in 1 of 2 comparable metrics.
Analyst Outlook
Evenly matched — PINC and CAH each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: PINC as "Hold", TDOC as "Hold", MCK as "Buy", CAH as "Buy". Consensus price targets imply 38.0% upside for CAH (target: $253) vs 4.6% for TDOC (target: $8). For income investors, PINC offers the higher dividend yield at 2.98% vs MCK's 0.42%.
| Metric | YI111, Inc. | PINCPremier, Inc. | TDOCTeladoc Health, I… | MCKMcKesson Corporat… | CAHCardinal Health, … |
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $33.15 | $7.58 | $994.86 | $253.38 |
| # AnalystsCovering analysts | — | 31 | 42 | 31 | 33 |
| Dividend YieldAnnual dividend ÷ price | — | +3.0% | — | +0.4% | +1.1% |
| Dividend StreakConsecutive years of raises | — | 1 | — | 18 | 20 |
| Dividend / ShareAnnual DPS | — | $0.84 | — | $3.07 | $2.04 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +17.1% | 0.0% | 0.0% | +1.8% |
Evenly matched — PINC and CAH each lead in 1 of 2 comparable metrics.
Key Takeaway
MCK leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). YI leads in 1 (Valuation Metrics). 2 tied.
Best OverallMcKesson Corporation (MCK)Leads 2 of 6 categories
Loading custom metrics...
YI vs PINC vs TDOC vs MCK vs CAH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is YI or PINC or TDOC or MCK or CAH a better buy right now?
For growth investors, McKesson Corporation (MCK) is the stronger pick with 12.
4% revenue growth year-over-year, versus -10. 9% for Premier, Inc. (PINC). McKesson Corporation (MCK) offers the better valuation at 19. 2x trailing P/E (16. 7x forward), making it the more compelling value choice. Analysts rate McKesson Corporation (MCK) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — YI or PINC or TDOC or MCK or CAH?
On trailing P/E, McKesson Corporation (MCK) is the cheapest at 19.
2x versus Premier, Inc. at 128. 5x. On forward P/E, McKesson Corporation is actually cheaper at 16. 7x.
03Which is the better long-term investment — YI or PINC or TDOC or MCK or CAH?
Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +270.
4%, compared to -94. 9% for Teladoc Health, Inc. (TDOC). Over 10 years, the gap is even starker: MCK returned +339. 0% versus YI's -95. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — YI or PINC or TDOC or MCK or CAH?
By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at -0.
02β versus Teladoc Health, Inc. 's 1. 89β — meaning TDOC is approximately -11654% more volatile than MCK relative to the S&P 500. On balance sheet safety, Premier, Inc. (PINC) carries a lower debt/equity ratio of 18% versus 110% for McKesson Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — YI or PINC or TDOC or MCK or CAH?
By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 12.
4% versus -10. 9% for Premier, Inc. (PINC). On earnings-per-share growth, the picture is similar: Cardinal Health, Inc. grew EPS 87. 0% year-over-year, compared to -78. 8% for Premier, Inc.. Over a 3-year CAGR, MCK leads at 13. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — YI or PINC or TDOC or MCK or CAH?
Premier, Inc.
(PINC) is the more profitable company, earning 2. 0% net margin versus -7. 9% for Teladoc Health, Inc. — meaning it keeps 2. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MCK leads at 1. 5% versus -10. 4% for TDOC. At the gross margin level — before operating expenses — PINC leads at 73. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is YI or PINC or TDOC or MCK or CAH more undervalued right now?
On forward earnings alone, McKesson Corporation (MCK) trades at 16.
7x forward P/E versus 20. 8x for Premier, Inc. — 4. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CAH: 38. 0% to $253. 38.
08Which pays a better dividend — YI or PINC or TDOC or MCK or CAH?
In this comparison, PINC (3.
0% yield), CAH (1. 1% yield), MCK (0. 4% yield) pay a dividend. YI, TDOC do not pay a meaningful dividend and should not be held primarily for income.
09Is YI or PINC or TDOC or MCK or CAH better for a retirement portfolio?
For long-horizon retirement investors, Cardinal Health, Inc.
(CAH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 1. 1% yield, +158. 8% 10Y return). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 89 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CAH: +158. 8%, TDOC: -38. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between YI and PINC and TDOC and MCK and CAH?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
PINC, CAH pay a dividend while YI, TDOC, MCK do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(YI: -6.4% · PINC: -3.3%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.